A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Authors: Vincent Ribrag, Seung‐Tae Lee, David A. Rizzieri, Martin J.S. Dyer, Luis Fayad, Razelle Kurzrock, Leslie A. Andritsos, Réda Bouabdallah, Amjad Hayat, Larry Bacon, Yu Jiang, Kowser Miah, Bruno Delafont, Oday Hamid, S. Anyanwu, Pablo Martínez, Brian Hess - Clinical Lymphoma Myeloma & Leukemia 2020 cited by 28